Biopharma Start-Up Formation and Funding Primer

Biopharma Start-Up Formation and Funding Primer

Biopharma Start-Up Formation and Funding Primer is a 60-minute live course exploring the early-stage pharmaceutical and biotech funding landscape and R&D dynamics. Since the 1980s, these sectors have seen increased R&D investment, with innovation shifting towards smaller companies and academic institutions. The drug development process often begins in universities with NIH funding, involving licensing through multiple entities. Preclinical funding comes from grants and seed investors, while venture capital and strategic partnerships drive clinical development. IPOs and reverse mergers provide public market access, highlighting the essential role of institutional investor support. Join Biotech Primer on February 12, 2025, from 12 noon to 1:00 pm ET for this free course.

Takeaways

1. Examine the shift from in-house R&D to outsourced innovation, focusing on start-ups and academic collaborations.
2. Explore academic-startup licensing models, including upfront payments, equity stakes, and milestone-based agreements.
3. Learn the trends in early-stage biopharma investments.
4. Discuss out-licensing deals from startups to large pharma and recent shifts in the field
5. Review funding options at different stages, such as NIH grants, venture debt, and public market options.